Catalysts for $COLL
120 tracked
Dec 15, 2023
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 15, 2023
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Dec 15, 2023
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 15, 2023
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 13, 2023
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 13, 2023
approval
RELEXXII (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 13, 2023
approval
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 13, 2023
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 13, 2023
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jul 3, 2023
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jul 3, 2023
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jun 23, 2022
approval
RELEXXII (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jun 25, 2021
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jun 25, 2021
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jun 25, 2021
approval
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jun 25, 2021
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jun 25, 2021
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Mar 4, 2021
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Mar 4, 2021
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Mar 4, 2021
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Mar 4, 2021
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 6, 2020
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 7, 2019
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 7, 2019
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Oct 7, 2019
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 7, 2019
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jun 14, 2019
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
May 16, 2019
approval
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 26, 2018
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Sep 18, 2018
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→